Bupropion has been linked to menstrual changes in a small number of documented cases, including irregular bleeding, shortened cycles, and even the temporary disappearance of periods. The evidence, however, comes almost entirely from individual case reports rather than large studies, which makes it difficult to say how common these effects are. What makes the picture more complicated is that depression itself can disrupt menstrual cycles through overlapping hormonal pathways, so teasing apart what the drug is doing from what the underlying condition is doing is genuinely tricky.
The Case Reports That Raised the Question
The first published report linking bupropion to menstrual irregularities appeared in 1991, when clinicians documented two patients who developed cycle disruptions while taking the medication. The report noted that the association was further supported by surveillance data collected by the drug’s original manufacturer at the time.1PubMed. Menstrual irregularities associated with bupropion treatment Decades later, a 2022 case report described a patient who developed abnormal uterine bleeding while on bupropion. That paper also noted that the earlier case series had documented one patient with irregular and heavier menstrual bleeding and another with shortened cycles that progressed to a complete loss of periods.2Bagcilar Medical Bulletin. Abnormal Uterine Bleeding Associated with Bupropion: A Case Report
The total number of published cases is extremely small. That does not mean bupropion rarely affects periods; it may mean the effect is underreported, poorly recognized, or difficult to separate from other causes. Case reports are the starting point for identifying drug side effects, not the endpoint. But no randomized trial or large observational study has specifically tracked menstrual outcomes in people taking bupropion, so the evidence base remains thin.
How Bupropion Could Plausibly Alter the Cycle
Bupropion works differently from most antidepressants. It blocks the reuptake of norepinephrine and dopamine without meaningfully touching serotonin.3PubMed Central. A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor This distinction matters for menstrual effects because dopamine and norepinephrine both play regulatory roles in the hormonal chain that controls ovulation and the menstrual cycle.
Dopamine, in particular, is a key regulator of prolactin release from the pituitary gland. More dopamine activity typically means lower prolactin. Changes in prolactin levels can interfere with the pulsing release of the hormones that trigger ovulation. Norepinephrine, meanwhile, influences the hypothalamic-pituitary-adrenal (HPA) axis, which governs the body’s stress response. The HPA axis and the reproductive axis share real estate in the hypothalamus, and when one system is pushed hard, the other can get knocked off balance.
A study examining bupropion’s effects on the HPA axis found that, unlike many other antidepressants, eight weeks of bupropion treatment did not reduce HPA activity. In that study, people who did not respond to bupropion actually showed an increase in nighttime cortisol after a single dose, while those who went on to respond showed no such spike.4PubMed. Effect of bupropion on nocturnal urinary free cortisol and its association with antidepressant response Cortisol is relevant here because elevated cortisol is one of the mechanisms through which stress and depression are thought to disrupt menstrual cycles. If bupropion does not calm the cortisol response in some patients, the cycle-disrupting stress physiology may persist even as mood symptoms improve.
None of this proves a direct causal chain from bupropion to missed or irregular periods. But the drug’s dopaminergic and noradrenergic effects provide plausible biological routes through which menstrual disturbances could occur. The handful of case reports are at least consistent with what pharmacology would predict.
When Depression Itself Is Disrupting Your Cycle
One of the trickiest parts of evaluating whether bupropion is causing menstrual changes is that depression itself is a well-documented disruptor of the menstrual cycle. The hormonal cascade works like this: depression is associated with excessive release of corticotropin-releasing hormone, which drives up cortisol. Elevated cortisol then suppresses the pulsing signals from the hypothalamus that tell the pituitary to release the hormones needed for ovulation. Researchers have observed changes in the amplitude and pulse frequency of luteinizing hormone, as well as shifts in follicle-stimulating hormone levels, in people with depression.5PubMed Central. Depression and Its Effect on the Menstrual Cycle
In practice, this means someone starting bupropion for depression may already have a disrupted cycle before the first pill. If the disruption becomes more noticeable after starting treatment, it is easy to assume the medication caused it, when in reality the depression was already doing the damage. Conversely, if your cycle was normal before starting bupropion and becomes irregular afterward, that temporal connection is worth taking seriously, even though it does not prove causation on its own.
The challenge for clinicians is that there is no simple blood test that distinguishes “your depression shifted your hormones” from “your medication shifted your hormones.” Both routes converge on the same downstream effects: altered signaling in the hypothalamus and pituitary that can shorten, lengthen, or eliminate cycles. When someone reports menstrual changes after starting bupropion, the honest clinical answer is often that both the disease and the drug could be contributing, and separating them requires careful observation over time.
The Weight-Loss Factor
Bupropion is one of the few antidepressants associated with weight loss rather than weight gain. For some people, this is a welcome effect, but rapid or significant weight loss carries its own reproductive consequences. The hypothalamic-pituitary-ovarian axis is sensitive to energy balance. When the body perceives that calorie intake is falling short of expenditure, it can dial down reproductive signaling as a conservation measure.
A narrative review on weight-loss-related amenorrhea noted that misuse or off-label use of weight-loss medications can cause pronounced weight loss in a short period, leading to suppression of the reproductive axis and resulting in menstrual irregularity or complete loss of periods.6PubMed Central. The effects of weight loss-related amenorrhea on women’s health and the therapeutic approaches: a narrative review While that review was discussing weight-loss drugs broadly rather than bupropion specifically, the principle applies: if bupropion causes enough appetite suppression and weight loss in a given person, the weight change alone could account for a shift in cycle regularity.
This is especially relevant because bupropion is sometimes prescribed in combination with naltrexone specifically for weight management. Someone taking bupropion in that context may experience more dramatic weight changes than someone taking it purely for depression. If you notice menstrual changes alongside significant weight loss on bupropion, the weight loss itself may be the more likely culprit than a direct pharmacological effect on reproductive hormones. Restoring adequate caloric intake typically allows the axis to recover.
Bupropion and Hormonal Contraceptives
If you take both bupropion and a hormonal birth control pill, there is a pharmacokinetic interaction worth knowing about. Bupropion is primarily metabolized in the liver by an enzyme called CYP2B6. Oral contraceptives inhibit this enzyme, which changes how your body processes bupropion. A study measuring this interaction found that oral contraceptive use reduced the formation of bupropion’s main active metabolite, hydroxybupropion, by roughly a third.7PubMed. Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation
What does this mean in practical terms? Less hydroxybupropion could potentially reduce the drug’s antidepressant effect, since hydroxybupropion is pharmacologically active and contributes to bupropion’s clinical activity. The interaction does not appear to change the overall ratio of metabolite to parent drug in a way that dramatically shifts the drug’s profile, but it is a factor your prescriber should be aware of if you are on both medications and feel bupropion is not working as well as expected.
There is no strong evidence that this interaction works the other way, meaning bupropion does not appear to reduce the contraceptive effectiveness of birth control pills. But if bupropion’s antidepressant effect is weakened by oral contraceptives, undertreated depression could itself perpetuate the cycle disruptions described earlier. It is a subtle chain of effects that is easy to overlook.
Does Bupropion Help with Premenstrual Symptoms?
Given that bupropion can potentially disrupt the cycle, you might wonder whether it offers any benefit for premenstrual symptoms. The short answer is that it performs poorly for this purpose compared with serotonin-targeting antidepressants. A controlled trial comparing fluoxetine, bupropion, and placebo for premenstrual dysphoric disorder found that fluoxetine was significantly more effective than both bupropion and placebo. Bupropion produced results that fell somewhere between fluoxetine and placebo, but the difference from placebo was not statistically meaningful.8PubMed. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder
This finding is consistent with what we know about premenstrual dysphoric disorder (PMDD). Serotonin appears to play a central role in PMDD symptoms, which explains why selective serotonin reuptake inhibitors are the first-line treatment. Bupropion’s lack of serotonergic activity, the same feature that spares it from many of the sexual side effects associated with SSRIs, also means it lacks the mechanism that makes SSRIs effective for PMDD.3PubMed Central. A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor If severe premenstrual symptoms are a primary concern, bupropion is not the antidepressant most likely to help.
How Other Antidepressants Compare
Bupropion is far from the only antidepressant that can affect menstrual cycles. SSRIs and serotonin-norepinephrine reuptake inhibitors (SNRIs) have their own track records of cycle disruption, including reports of heavy bleeding, spotting between periods, and missed periods. Serotonin influences platelet aggregation, which is one reason serotonin-active drugs are sometimes linked to heavier menstrual bleeding. Bupropion lacks this serotonergic pathway, so if heavier bleeding is the primary concern, the mechanism is likely different from what happens with SSRIs.
The broader pattern in the literature is that nearly every class of psychotropic medication has been associated with menstrual changes in at least some patients. Antipsychotics, particularly those that raise prolactin levels, are probably the most reliable offenders. Mood stabilizers like valproate are known to contribute to polycystic ovarian changes. Among antidepressants, the reports are scattered across drug classes, and no single agent stands out as dramatically worse than the others for menstrual regularity. What distinguishes bupropion is primarily its mechanism: the dopaminergic and noradrenergic effects create a different pharmacological profile, which means that if one antidepressant is causing cycle problems, switching to another class sometimes resolves the issue.
What to Do If Your Cycle Changes on Bupropion
If you notice your period becoming irregular, heavier, lighter, or disappearing after starting bupropion, a few practical steps can help you and your clinician figure out what is going on.
- Track the timeline: Note when the change started relative to when you began the medication or had a dose adjustment. A change that coincides closely with starting or increasing bupropion is more suggestive of a drug effect than one that emerges months later.
- Monitor weight: If you have lost a significant amount of weight since starting bupropion, that alone could explain the cycle disruption. Even a loss of 5 to 10 percent of body weight over a short period can be enough to interfere with ovulation in some people.
- Consider your depression: If depressive symptoms are still poorly controlled, the ongoing hormonal effects of depression on the reproductive axis may be a bigger factor than the medication itself.
- Rule out other causes: Thyroid disorders, polycystic ovary syndrome, pregnancy, perimenopause, and other medical conditions are far more common causes of menstrual irregularity than bupropion. A basic workup from your clinician can help exclude these.
If bupropion is strongly suspected as the cause and the menstrual changes are bothersome, your clinician may consider a dose reduction or a trial discontinuation to see if the cycle normalizes. In the published case reports, menstrual patterns did resolve after the medication was stopped or changed. Switching to an antidepressant with a different mechanism is another option, though this introduces the usual risks and adjustment period of any medication transition.
Why the Evidence Is So Thin
It is worth stepping back and asking why, after more than three decades on the market, the evidence on bupropion and menstrual cycles amounts to a handful of case reports. Part of the answer is structural: clinical trials for antidepressants historically have not tracked menstrual outcomes as a primary or even secondary endpoint. Cycle regularity is rarely asked about in standard depression rating scales, and unless a patient volunteers the information, it may never make it into the trial data.
There is also a reporting bias. Menstrual changes are common in the general population and have many possible causes, so neither patients nor clinicians may think to attribute them to an antidepressant. A patient whose period becomes irregular while starting bupropion may assume it is stress-related, and a clinician may agree. The result is that the signal, if it exists in a meaningful number of people, may be hidden in a sea of unattributed noise. The published case reports exist because individual clinicians were attentive enough to notice the pattern and motivated enough to write it up. For every published case, there are likely many unreported ones.
Pharmacovigilance databases, which collect spontaneous adverse event reports from patients and clinicians, may contain additional signals, but these databases have their own limitations. Reports are voluntary, unverified, and cannot establish causation. Until a study is specifically designed to monitor menstrual outcomes in people taking bupropion, the question of how common these effects are will remain genuinely unanswered. The existing evidence says the effect is biologically plausible and has been observed in real patients. It does not say how worried you should be.